The ROSA Shoulder system can support data-driven decision-making by leveraging patient-specific anatomical data. Credit: Terelyuk/shutterstock.com.

Zimmer Biomet has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for its ROSA Shoulder System, a robotic assistant for shoulder replacement surgery.

The ROSA Shoulder System expands the company’s ROSA Robotics portfolio, which already includes solutions for knee and hip replacement.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

It strengthens the company’s shoulder implant portfolio, which includes the Identity Shoulder System.

This system joins ZBEdge Dynamic Intelligence, augmenting the firm’s advanced digital and robotic technologies.

The ROSA Shoulder system is designed to offer versatility to surgeons for performing total shoulder replacements using either anatomic or reverse techniques, aiming for precise implant placement and improved patient outcomes.

It is also capable of reproducing humeral head resection and facilitating instrument insertion without requiring a central pin in the glenoid during surgery.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Furthermore, the system supports data-driven decision-making by leveraging patient-specific anatomical data.

Pre-operatively, it works with the Signature ONE Surgical Planning System 2.0 for 3D imaging, planning, and guide creation.

Intra-operatively, it provides real-time data to assist surgeons in glenoid and humeral positioning, potentially reducing patient complications.

Zimmer Biomet president and CEO Ivan Tornos said: “We are proud and excited to be the first company in the world to deliver a robotic surgical assistant for anatomic and reverse shoulder replacement surgery.

“ROSA Shoulder represents a novel advancement intended to help surgeons leverage the power of robotics and data analytics to perform highly complex shoulder procedures with accuracy and efficiency.”

Planned to be commercially available in the US in the latter half of this year, the system will also be compatible with the mymobility Digital Care Management Platform.

Last year, Zimmer agreed to acquire privately held medical device company OSSIS.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact